BioPharma Dive
JUNE 1, 2025
Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of initial treatment, potentially opening a novel step in patient care.
NY Times
JUNE 1, 2025
A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved their quality of life.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Joe
JUNE 1, 2025
In this episode, Ill discussexpectations for the onset of action of IM medications used for acute agitation. Episode 1031: How Long Does it Take for IM Medications to Work in Acute Agitation? Subscribe on iTunes , Android , or Stitcher When caring for an acutely agitated patient, the delay between IM medication administration and the onset of action can seem exceedingly long.
Pharmaceutical Commerce
JUNE 1, 2025
At Advanced Therapies Week 2025, Rohin Iyer, Senior Director of Global CGT Operations at Marken, sat down for an exclusive interview with Phacilitate, offering perspective on the transformative advancements, emerging challenges, and future directions shaping the advanced therapies landscape. In this compelling discussion, Rohin explores key trends, including the increasing approval rates of allogeneic and autologous therapies, the exponential growth in the cell and gene therapy sector, and the s
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
pharmaphorum
JUNE 1, 2025
Regeneron's PD-1 inhibitor Libtayo hits the mark where MSD's Keytruda missed in a form of non-melanoma skin cancer
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
JUNE 1, 2025
Gilead lays down a marker for AZ and Daiichi Sankyo to follow as Trodelvy scores in first-line treatment of triple-negative breast cancer (TNBC).
Pharmaceutical Commerce
JUNE 1, 2025
Radiopharmaceuticals are transforming cancer treatment, but their short half-lives and radioactive properties demand flawless, time-critical logistics. Markens integrated one UPS network ensures secure, temperature-controlled and compliant delivery every time - accelerating access to these life-saving therapies.
pharmaphorum
JUNE 1, 2025
Discover Johnson & Johnsons groundbreaking Breathtaking campaign, unveiled at ASCO 2025 in Chicago. Watch the exclusive interview with Biljana Naumovic for insights into J&Js patient-first approach and the Oncology Care Index.
Pharmaceutical Commerce
JUNE 1, 2025
When patients struggle to see a positive path forward, modeling a constructive journey can give them the confidence they need.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Dive
JUNE 1, 2025
An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a bispecific antibody newly licensed by Pfizer.
PharmaTech
JUNE 1, 2025
As described in the chapter subsection USP Package Seal Quality Test Methods, the measurement of residual seal force (RSF) indicates the quality of the vial package seal, giving insight into the quality of the sealing process. Correlating RSF to CCI data enables optimization and validation of the vial sealing process with parameters that give assurance of good CCI.
Pharmacy Times
JUNE 1, 2025
MRD testing transforms multiple myeloma treatment, guiding personalized strategies and improving patient outcomes through innovative testing methods.
PharmaTech
JUNE 1, 2025
Glycosylation is a common and critical post-translational modification that affects protein function and therapeutic efficacy, making its monitoring and accurate quantification essential for drug development.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharmacy Times
JUNE 1, 2025
Experts discuss BiTE therapy in treating lung cancers, focusing on innovative agents like tarlatamab and amivantimab, and their toxicity management.
PharmaTech
JUNE 1, 2025
This new case study demonstrates how a non-destructive container closure integrity test method can be developed for autoinjectors with an optically transparent window.
Pharmacy Times
JUNE 1, 2025
Brge G. Nordestgaard, MD, DMSc, discussed the role of remnant cholesterol as an independent risk factor for atherosclerotic cardiovascular disease and the emerging therapies that may help manage residual cardiovascular risk beyond low-density lipoprotein cholesterol reduction.
PharmaTech
JUNE 1, 2025
Webinar Date/Time: Thu, Jun 26, 2025 11:00 AM EDT
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmacy Times
JUNE 1, 2025
Incretin-based therapies, including GLP-1 and dual GLP-1/GIP receptor agonists, are transforming the management of type 2 diabetes, obesity, and cardiovascular risk.
PharmaTech
JUNE 1, 2025
Download this Case Study to learn how a purging process qualification study was performed using rapid non-destructive headspace oxygen analysis in an at-line set-up with samples being measured immediately from the line.
Pharmacy Times
JUNE 1, 2025
Frank Qian, MD, MPH, discusses clinical considerations for omega-3 fatty acid therapy, such as the patient populations who may benefit most and important safety concerns.
pharmaphorum
JUNE 1, 2025
Pfizer's BRAF inhibitor Braftovi achieved a 51% reduction in the risk of death in the BREAKWATER trial, setting up full FDA approval
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
STAT
JUNE 1, 2025
CHICAGO — An exercise program can reduce the risk that colorectal cancer will return after surgery and chemotherapy, according to a new study. The benefit from the study’s exercise program was about as large as what researchers might expect from a new drug, experts said, and came from a randomized controlled trial, the gold standard of medical research.
Express Pharma
JUNE 1, 2025
CAR-Ts are revolutionising the treatment of blood cancers, such as B-cell acute lymphocytic leukemia. However, their success has not yet extended to the realm of solid tumors, as no CAR-T therapy has advanced beyond Phase II in one of these indications. Overcoming current limitations and expanding the reach of CAR-T therapeutics could unlock promising new treatment possibilities for solid tumor patients, says GlobalData.
STAT
JUNE 1, 2025
This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more updates on the latest in cancer news, sign up for our Cancer Briefing newsletter here. We’re going to get to today’s new data in a minute, but first let’s deal with a less serious matter: the marketing of pharmaceutical products via the food attendees need to consume at giant medical meetings.
Med Ed 101
JUNE 1, 2025
When patients have anemia, supplements often get prescribed. To many of our polypharmacy patients, excessive prescribing can lead to an increase in pill burden that may not always be necessary. When looking at deprescribing supplements, anemia is an excellent disease state to reassess. Vitamin B12, iron, and folic acid are excellent targets for deprescribing supplements […] The post Deprescribing Supplements in Anemia appeared first on Med Ed 101.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JUNE 1, 2025
Kausik K. Ray, MD, discussed the importance of early, aggressive, and sustained LDL-C lowering for atherosclerotic cardiovascular disease prevention, highlighting that the magnitude of cardiovascular risk reduction is independent of the specific lipid-lowering therapy used.
FDA Law Blog: Biosimilars
JUNE 1, 2025
By Charles D. Snow & Dara Katcher Levy In a recent letter to FDA Commissioner Dr. Martin Makary, U.S. Senator Dick Durbin (D-IL) expressed concerns over the agencys ability to regulate direct-to-consumer (DTC) prescription drug advertisements following recent workforce reductions. In his letter, Senator Durbin highlighted FDAs critical role in ensuring that pharmaceutical advertisements are truthful, not misleading, and provide balanced information and asked a number of questions including
STAT
JUNE 1, 2025
In an interview meant to clarify the federal government’s position on Covid-19 vaccines, Food and Drug Administration Commissioner Marty Makary had few answers. Instead, he urged Americans to consult with their doctors. In a Sunday appearance on CBS News’ “Face the Nation,” Makary said the data on Covid shots in healthy children and pregnant people are mixed, and said the decision on whether to get vaccinated should be between patients and their doctors.
Expert insights. Personalized for you.
109 
Let's personalize your content